Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
French Ministry of Health prospective multicentre study using bio-active stents coated with titanium nitride oxide: the EVIDENCE registry.
Angioi M, Barragan P, Cattan S, Collet F, Dupouy P, Durand P, Fajadet J, Finet G, Gerardin B, Gommeaux A, Karsenty B, Loubeyre C, Meyer P, Morice MC, Moulichon MÉ, Sayah S, Silvestri M, Tabone X, Unterseeh T, Wittenberg O, Lablanche JM. Angioi M, et al. Among authors: wittenberg o. Arch Cardiovasc Dis. 2012 Feb;105(2):60-7. doi: 10.1016/j.acvd.2011.12.003. Epub 2012 Feb 19. Arch Cardiovasc Dis. 2012. PMID: 22424323 Free article.
Adjusted clopidogrel loading doses according to vasodilator-stimulated phosphoprotein phosphorylation index decrease rate of major adverse cardiovascular events in patients with clopidogrel resistance: a multicenter randomized prospective study.
Bonello L, Camoin-Jau L, Arques S, Boyer C, Panagides D, Wittenberg O, Simeoni MC, Barragan P, Dignat-George F, Paganelli F. Bonello L, et al. Among authors: wittenberg o. J Am Coll Cardiol. 2008 Apr 8;51(14):1404-11. doi: 10.1016/j.jacc.2007.12.044. J Am Coll Cardiol. 2008. PMID: 18387444 Free article. Clinical Trial.
Platelet glycoprotein IIb/IIIa inhibition with coronary stenting for acute myocardial infarction.
Montalescot G, Barragan P, Wittenberg O, Ecollan P, Elhadad S, Villain P, Boulenc JM, Morice MC, Maillard L, Pansiéri M, Choussat R, Pinton P; ADMIRAL Investigators. Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long-Term Follow-up. Montalescot G, et al. Among authors: wittenberg o. N Engl J Med. 2001 Jun 21;344(25):1895-903. doi: 10.1056/NEJM200106213442503. N Engl J Med. 2001. PMID: 11419426 Free article. Clinical Trial.
High on-treatment platelet reactivity after prasugrel loading dose and cardiovascular events after percutaneous coronary intervention in acute coronary syndromes.
Bonello L, Pansieri M, Mancini J, Bonello R, Maillard L, Barnay P, Rossi P, Ait-Mokhtar O, Jouve B, Collet F, Peyre JP, Wittenberg O, de Labriolle A, Camilleri E, Cheneau E, Cabassome E, Dignat-George F, Camoin-Jau L, Paganelli F. Bonello L, et al. Among authors: wittenberg o. J Am Coll Cardiol. 2011 Jul 26;58(5):467-73. doi: 10.1016/j.jacc.2011.04.017. J Am Coll Cardiol. 2011. PMID: 21777742 Free article. Clinical Trial.
Relationship between post-treatment platelet reactivity and ischemic and bleeding events at 1-year follow-up in patients receiving prasugrel.
Bonello L, Mancini J, Pansieri M, Maillard L, Rossi P, Collet F, Jouve B, Wittenberg O, Laine M, Michelet P, Bessereau J, Lemesle G, Dignat-George F, Paganelli F, Camoin-Jau L. Bonello L, et al. Among authors: wittenberg o. J Thromb Haemost. 2012 Oct;10(10):1999-2005. doi: 10.1111/j.1538-7836.2012.04875.x. J Thromb Haemost. 2012. PMID: 22863374 Free article.
Usefulness and clinical impact of a fractional flow reserve and angiographic targeted strategy for coronary artery stenting: FROST III, a multicenter prospective registry.
Dupouy P, Gilard M, Morelle JF, Furber A, Aptecar E, Cazaux P, Slama M, Feldman LJ, Wittenberg O, Pernès JM, Huret B, Commeau P, Boschat J, Teiger E, Lafont A, Steg PG, Dubois Randé JL. Dupouy P, et al. Among authors: wittenberg o. EuroIntervention. 2005 May;1(1):85-92. EuroIntervention. 2005. PMID: 19758882
Initial and follow-up results of the European Seaquence coronary stent registry.
Hamon M, Petrescu V, Rossi P, Commeau P, Wittenberg O, Jouve B, Brunel P, Gommeau A, Macaya C, Betriu A, Serra A, Viecca M, Bortone A, Marzocchi A, Bush U, Grube E, Blanke H, Fleck E, Grollier G. Hamon M, et al. Among authors: wittenberg o. J Interv Cardiol. 2004 Feb;17(1):9-15. doi: 10.1111/j.1540-8183.2004.00243.x. J Interv Cardiol. 2004. PMID: 15009764
Everolimus-eluting stent for the treatment of bare metal in-stent restenosis: clinical and angiographic outcomes at nine-month follow-up of XERES (Xience Evaluation in bare metal stent REStenosis) trial.
Carrié D, Delarche N, Piot C, Berland J, Menneveau N, Bonello L, Py A, Teiger E, Leborgne L, Bayet G, Wittenberg O, Schiele F. Carrié D, et al. Among authors: wittenberg o. EuroIntervention. 2014 Oct;10(6):700-8. doi: 10.4244/EIJV10I6A122. EuroIntervention. 2014. PMID: 24334825 Free article. Clinical Trial.
Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
Bertinchant JP, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F, Brunet J, Poirey S, Wittenberg O, Pernel I, Nigond J. Bertinchant JP, et al. Among authors: wittenberg o. Am J Cardiol. 1999 Jul 1;84(1):51-7. doi: 10.1016/s0002-9149(99)00191-5. Am J Cardiol. 1999. PMID: 10404851
19 results